Perioperative chemotherapy is entirely based on patient age, tumor size, histologic grade, lymph node metastases, hormone receptor status, and HER2 status (7), (8), and it has contributed to the decrease in breast cancer mortality recently (9). The gene discussed is ERBB2; the disease is breast cancer.